Haisco's innovative drug hydrochloride succinate approved for listing
Regulatory approval brings a new pharmaceutical product into supply.
Source →The trace
How it reaches your house.
Starting from Zhejiang Huahai Pharmaceutical, we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
First impact
Zinc Chloride (Pharmaceutical Grade) →Stands to benefitCanada supplies 35.7% of pharmaceutical-grade zinc chloride, so incremental demand from the approved product should disproportionately benefit Canadian supply.
67% confidenceZinc Chloride (Pharmaceutical Grade) →Stands to benefitGermany (Federal Republic of Germany)
Germany supplies 17% of pharmaceutical-grade zinc chloride, so the new product's demand should lift demand for German supply as well.
62% confidenceZinc Chloride (Pharmaceutical Grade) →Stands to benefitThe United Kingdom supplies 9.6% of pharmaceutical-grade zinc chloride, so it should see a smaller but still positive demand benefit.
58% confidenceZinc Chloride (Pharmaceutical Grade) →Prices riseIf the newly approved product draws additional pharmaceutical-grade zinc chloride into production, insulin faces higher input costs because zinc chloride is a 0.65-strength supply input.
50% confidence
Where it lands
What you buy, and what you own.
Goods you buy
Insulin
Companies you may own
No named companies on this path.
Tap a company to see what it told the SEC could break it.
In the MyPRIA app, this is checked against your own holdings.